Automated Accounts Payable provider Glantus Holdings raises 14M and successfully floats on AIM. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7,864.00
Bid: 7,862.00
Ask: 7,864.00
Change: 12.00 (0.15%)
Spread: 2.00 (0.03%)
Open: 7,880.00
High: 7,882.00
Low: 7,825.00
Yest. Close: 7,852.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

NIH 'very concerned' about serious side effect in AstraZeneca vaccine trial - CNN

Wed, 16th Sep 2020 15:24

(Sharecast News) - The US part of the phase three trial of the Covid-19 vaccine candidate being developed by AstraZeneca and the University of Oxford remains on hold, pending authorisation for a restart from independent safety monitors and America's health regulator, the Food and Drug Administration.
Anthony Fauci, the top US infectious disease expert reportedly told CNN it was probably only a matter of time before they recommenced, Bloomberg reported.

However, Dr. Avindra Nath, an intramural director at a division of the US National Institutes of Health, told the same broadcaster on Tuesday that "the highest levels of NIH are very concerned".

UK health regulators cleared AstraZeneca and Oxford to restart the trial at the weekend, days after they were paused due to a potential illness among one participant of unknown cause.

That volunteer had since recovered and was no longer hospitalised.

Nonetheless, according to Dr. Nath, "AstraZeneca "need[s] to be more forthcoming with a potential complication of a vaccine which will eventually be given to millions of people," said Nath.

"We would like to see how we can help, but the lack of information makes it difficult to do so."

Nath said the NIH had yet to receive tissue or blood samples from the British volunteer that fell ill and that an investigation by US scientists was "in the planning staged" with the associated studies possibly taking a month or two to conduct.

More News

Friday broker round-up

(Sharecast News) - NCC Group: Canaccord upgrades to buy with a target price of 318p.

14 May 21 12:57

UK prepares to 'flex' vaccination program to tackle Indian Covid-19 variant

(Sharecast News) - UK vaccines minister Nadhim Zahawi said on Friday that the government was gearing up to "flex" its inoculation program in order to tackle the new coronavirus variant first detected in India.

14 May 21 11:16

INSIGHT-Big promises, few doses: why Russia's struggling to make Sputnik V doses

* Russia has touted Sputnik V vaccine around world* Vaccine production and exports lower than expected* Manufacturers face a series of big challenges* Hurdles serve as a warning to foreign partnersBy Polina Nikolskaya and Polina IvanovaMOSCOW, May 1...

14 May 21 07:00

Mexico's first locally produced AstraZeneca vaccines to be ready in May

MEXICO CITY, May 13 (Reuters) - Mexico's Finance Minister Arturo Herrera said on Thursday that the first batch of AstraZeneca COVID-19 vaccines bottled in Mexico would be ready later this month, after delays in starting operations at a local fact...

13 May 21 19:18

UPDATE 1-Quebec stops offering first doses of AstraZeneca vaccine

(Adds background)TORONTO, May 13 (Reuters) - The Canadian province of Quebec will no longer offer first doses of the AstraZeneca COVID-19 vaccine as of Thursday, but will offer second doses using current supplies and future deliveries, the provinc...

13 May 21 17:36

UPDATE 1-Egypt receives 2.2 mln AstraZeneca and Sinopharm vaccine doses

(Adds Sinopharm delivery, details)CAIRO, May 13 (Reuters) - Egypt has received a batch of more than 1.7 million doses of the AstraZeneca vaccine through the COVAX initiative and a separate shipment of 500,000 Sinopharm vaccine doses from China, th...

13 May 21 17:12

Quebec to stop offering first shots of AstraZeneca vaccine

TORONTO, May 13 (Reuters) - The Canadian province of Quebec will no longer offer first doses of the AstraZeneca COVID-19 vaccine as of Thursday, but will offer second doses using current supplies and future deliveries, the province's health minis...

13 May 21 16:30

RPT-INSIGHT-Top scientists question the need for COVID-19 booster shots

(Repeats to fix formatting without change to text)By Julie Steenhuysen and Kate KellandMay 13 (Reuters) - COVID-19 vaccine developers are making ever bolder assertions that the world will need yearly booster shots, or new vaccines to tackle concern...

13 May 21 14:01

INSIGHT-Top scientists question the need for COVID-19 booster shots

By Julie Steenhuysen and Kate Kelland May 13 (Reuters) - COVID-19 vaccine developers are making ever bolder assertions that the world will need yearly booster shots, or new vaccines to tackle concerning coronavirus variants, but some scie...

13 May 21 11:00

Egypt receives 1.7 mln AstraZeneca vaccine doses through COVAX

CAIRO, May 13 (Reuters) - Egypt has received a batch of more than 1.7 million doses of the AstraZeneca vaccine through the COVAX initiative, the health ministry said on Thursday.Egypt received its first COVAX delivery of 854,000 AstraZeneca doses...

13 May 21 09:29

UPDATE 3-Taiwan proposes $7.5 bln in spending as domestic COVID-19 cases rise

(Adds Taiwan president comments)TAIPEI, May 13 (Reuters) - Taiwan's government proposed on Thursday an extra T$210 billion ($7.5 billion) in spending to help the economy deal with the COVID-19 pandemic, as it reported 13 new domestic cases amid a ...

13 May 21 02:09

Delaying second COVID-19 vaccine doses can help reduce deaths - study

LONDON, May 12 (Reuters) - Giving a first dose of COVID-19 vaccine but delaying a second dose among people younger than 65 could lead to fewer people dying of the disease, but only if certain conditions are met, a predictive modelling study showed...

12 May 21 23:30

MEDIA-Russian plant to produce first AstraZeneca vaccine batches in June - RBC

May 12 (Reuters) -* Russian pharmaceutical firm R-Pharm will in June start producing the first doses in Russia of the COVID-19 vaccine developed by AstraZeneca and Oxford University, RBC magazine reported on Wednesday, citing the company's direct...

12 May 21 18:39

UPDATE 1-Swiss aim to re-open economy, donate AstraZeneca COVID-19 shots

(Adds comment from health minister)By John MillerZURICH, May 12 (Reuters) - Switzerland aims to expand its economic re-opening and may donate millions of AstraZeneca COVID-19 vaccine doses to developing countries as the Alpine nation grows increas...

12 May 21 16:05

UPDATE 1-More data needed before COVID-19 vaccine booster call - EU regulators

(Adds details, quotes, background)May 12 (Reuters) - More clinical and real-world data is needed on how well and for how long COVID-19 vaccines are protective before any decisions should be made on offering third or booster doses, Europe's drug re...

12 May 21 14:46

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.